Published on: April 9, 2017
by Women’s Brain Health Initiative:
Join Women’s Brain Health Initiative for an enlightening panel discussion on the implications of legalizing marijuana, and listen to the experts describe the medical, legal, investor, political and business perspectives.
Managing Principal at Navigator
Shelley Brown – Employment Lawyer, Steinberg Title Hope & Israel LLP
Alan Gertner – CEO, Tokyo Smoke
Alison Gordon – VP, Business Strategy, Marketing & Communications, Delshen Therapeutics
Matei Olaru – CEO, Lift
Aaron Salz – CEO Stoic Advisory
Dr. Mark Ware – Clinical Research Director, Alan Edwards Pain Management Unit and Cannabis Researcher, McGill University
Enjoy cocktails and light fare.
Tuesday April 18, 2017 | 6:00 – 9:00 p.m.
Navigator Ltd. | 121 King St. W. Suite 1810
General Admission: $60 | Group Rate: $50 ea.
This event is free to Millennial Members.
Members, please call 416-927-2011 to reserve your seat!
Membership information available at
Proceeds support Women’s Brain Health Initiative
*Charitable receipt issued for maximum allowable by law.
Generously Sponsored By:
Navigator & Brain Canada
While anyone can experience a stroke at any age, women experience more stroke events than men and are less likely to recover. “BE FAST” is a checklist of 6 items to keep in mind when assessing whether you might be...
Enjoy these highlights from our Engaging Millennial Minds Chew on This virtual event with celebrity chef Mark McEwan.
This virtual culinary event featured Celebrity Chef and Restauranteur Mark McEwan.
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.